Management of Venous Thromboembolism in Children: Current Recommendations and Therapeutic Options
Alessandra Bosch, Manuela Albisetti Division of Hematology, University Children’s Hospital, Zurich, SwitzerlandCorrespondence: Manuela AlbisettiDivision of Hematology, University Children’s Hospital, Steinwiesstrasse 75, Zurich CH-8032, SwitzerlandTel +41 44 266 7138Fax +41 44 26...
Guardado en:
Autores principales: | Bosch A, Albisetti M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/493c3c5977e244bda0ff3f9a6d95d4d5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diagnostic and Prognostic Value of Immune/Inflammation Biomarkers for Venous Thromboembolism: Is It Reliable for Clinical Practice?
por: Xue J, et al.
Publicado: (2021) -
Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors
por: Xue-lin Zou, et al.
Publicado: (2021) -
Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban
por: Kwong LM
Publicado: (2013) -
Mean platelet volume as a prognostic factor for venous thromboembolic disease
por: Díaz,Juan Manuel, et al.
Publicado: (2019) -
Oxidative Stress in the Pathogenesis of Antiphospholipid Syndrome: Implications for the Atherothrombotic Process
por: Cristina Nocella, et al.
Publicado: (2021)